GLP-1 medicines and alcohol

Overview

Alcohol is not an absolute contraindication, but it interacts badly with three things GLP-1 therapy already affects: hydration, nausea and blood glucose.

Why it's done and who it helps

• Alcohol worsens dehydration, a key acute kidney injury risk.
• Nausea and reflux are commonly amplified.
• Alcohol adds substantial empty calories and stalls weight loss.
• Hypoglycaemia risk rises if you also take insulin or a sulfonylurea.

Practical limits

UK guidance is no more than 14 units a week spread over three or more days, with drink-free days. In CKD, less is better.

Fluid-restricted patients

If you are on a fluid restriction for dialysis, alcohol counts towards your daily allowance and does not quench thirst.

Many people simply drink less

Reduced desire for alcohol is a commonly reported effect of GLP-1 therapy and is generally a welcome one.

Preparing for your appointment

Can I drink on the day of my injection?

There is no timing rule, but symptoms are often worse in the first 48 hours after a dose.

Does alcohol damage my kidneys?

Heavy drinking raises blood pressure and dehydration risk, both harmful in CKD.

When to contact your care team

Contact the clinic promptly if you have any of the following:

• Vomiting or diarrhoea lasting more than 24 hours, or you cannot keep fluids down
• Passing much less urine than usual, or new swelling of the legs or face
• Severe pain in the upper abdomen that spreads to your back, with or without vomiting
• A weight change of more than 2 kg in a week that is not explained by fluid
• A missed weekly weight, a missed dose, or any hospital admission

If you are seriously unwell, contact NHS 111 or your renal unit directly rather than waiting for your next review.

Your care at KidneyWeight Clinic

Every dose change, weekly weight and kidney blood test is recorded in your clinical monitoring record, reviewed by Professor Mohammed Mahdi Althaf at six-weekly intervals and formally reassessed at 26 weeks. Booking and your initial payment are handled by professoralthaf.co.uk, medication supply by Healist Pharmacy, and follow-up appointment payments by Carebit.

References

• NICE TA1026: tirzepatide for managing overweight and obesity
• NICE TA875: semaglutide for managing overweight and obesity
• NICE CG189: obesity identification, assessment and management
• NHS: weight-loss medicines

This article is general patient information reviewed by a consultant nephrologist. It is not individual medical advice; treatment decisions are made at a face-to-face consultation.